Maria Rosaria Ambrosio (M R Ambrosio, Maria Chiara Zatelli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Replacement Therapy

Rheumatoid Arthritis Patients

Disease Activity

Top Venues

Journal of endocrinological investigation

Journal of community genetics

Endocrinology, diabetes & metabolism case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Rosaria Ambrosio, Irene Gagliardi, Luisa Valente, Antonio Stefanelli, Luca Borgatti, Elena Franco, Manlio Galiè, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves' orbitopathy: a case report and literature review. Endocrine 85 (2) (2024)
Maria Rosaria Ambrosio, Irene Gagliardi, Luisa Valente, Antonio Stefanelli, Luca Borgatti, Elena Franco, Manlio Galiè, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves' orbitopathy: a case report and literature review. Endocrine (2024)
Maria Rosaria Ambrosio, Irene Gagliardi, Luisa Valente, Antonio Stefanelli, Luca Borgatti, Elena Franco, Manlio Galiè, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves' orbitopathy: a case report and literature review. Endocrine 85 (2) (2024)
Maria Rosaria Ambrosio, Irene Gagliardi, Luisa Valente, Antonio Stefanelli, Luca Borgatti, Elena Franco, Manlio Galiè, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves' orbitopathy: a case report and literature review. Endocrine 85 (2) (2024)
Maria Chiara Zatelli, Valentino Marino Picciola, Maria Rosaria Ambrosio, Maria Rosaria Ambrosio
Pituitary and COVID-19 vaccination: a systematic review. Pituitary (2024)
L Aliberti, I Gagliardi, M Pontrelli, M C Zatelli, Maria Rosaria Ambrosio
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment. Endocrinology, diabetes & metabolism case reports 2023 (1) (2023)
Marta Bondanelli, Ludovica Aliberti, Irene Gagliardi, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Long-term low-dose tolvaptan efficacy and safety in SIADH. Endocrine (2023)
Ludovica Aliberti, Irene Gagliardi, S Lupo, M Verrienti, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Investigation of COVID-19 infection in subjects with Klinefelter syndrome. Journal of endocrinological investigation 45 (5) (2022)
Ludovica Aliberti, Irene Gagliardi, Maria Rita Gamberini, Andrea Ziggiotto, Martina Verrienti, Aldo Carnevale, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria. British journal of haematology 198 (5) (2022)
Irene Gagliardi, Mariella Celico, Maria Rita Gamberini, Margherita Pontrelli, Monica Fortini, Aldo Carnevale, Nicola Napoli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience. Calcified tissue international 111 (1) (2022)
Irene Gagliardi, R Mungari, M R Gamberini, M Fortini, Francesca Dassie, M C Putti, P Maffei, Ludovica Aliberti, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study. Journal of endocrinological investigation 45 (7) (2022)
Ludovica Aliberti, Irene Gagliardi, Stefania Bigoni, S Lupo, S Caracciolo, Alessandra Ferlini, Andrea M Isidori, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? Journal of community genetics 13 (3) (2022)
Irene Gagliardi, Alessandro Mella, Paola Franceschetti, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget. Endocrine (2021)
Irene Gagliardi, Alessandro Mella, Paola Franceschetti, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget. Endocrine (2021)
Ludovica Aliberti, Irene Gagliardi, Romolo M Dorizzi, Stefano Pizzicotti, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Hypeprolactinemia: still an insidious diagnosis. Endocrine 72 (3) (2020)
Vincenzo Rochira, G Mossetto, N Jia, Salvatore Cannavò, P Beck-Peccoz, Gianluca Aimaretti, Maria Rosaria Ambrosio, Carolina Di Somma, M Losa, D Ferone, C Lubrano, Carla Scaroni, Antonella Giampietro, S M Corsello, M Poggi
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS). Journal of endocrinological investigation 41 (11) (2018)